Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Nunn

Showing results (111-120 of 130) with videos related to

Pageof 13
Sort By:
The Journal of Biological Chemistry|April 30, 2013
Bifunctional lipocalin ameliorates murine immune complex-induced acute lung injuryPietro Roversi, Bernhard Ryffel, Dieudonnée Togbe, et al.
British Journal of Pharmacology|October 17, 2022
Immunopathology of terminal complement activation and complement C5 blockade creating a pro-survival and organ-protective phenotype in traumaZhangsheng Yang, Miles A Nunn, Tuan D Le, et al.
Blood Advances|January 4, 2018
Use of the complement inhibitor Coversin to treat HSCT-associated TMATimothy H J Goodship, Fernando Pinto, Wynn H Weston-Davies, et al.
Brain : a Journal of Neurology|August 31, 2010
Systemic blockade of P2X3 and P2X2/3 receptors attenuates bone cancer pain behaviour in ratsTimothy K Y Kaan, Ping K Yip, Sital Patel, et al.
The Biochemical Journal|June 16, 2010
Crystal structure and functional characterization of an immunomodulatory salivary cystatin from the soft tick Ornithodoros moubataJirí Salát, Guido C Paesen, Pavlína Rezácová, et al.
Lancet (London, England)|November 5, 1997
HIV-1 viral load, phenotype, and resistance in a subset of drug-naive participants from the Delta trial. The National Virology Groups. Delta Virology Working Group and Coordinating CommitteeF Brun-Vézinet, C Boucher, C Loveday, et al.
Critical Care (London, England)|November 28, 2015
Combined inhibition of complement and CD14 improved outcome in porcine polymicrobial sepsisEspen W Skjeflo, Caroline Sagatun, Knut Dybwik, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 6, 2021
Preclinical Efficacy and Anti-Inflammatory Mechanisms of Action of the Bruton Tyrosine Kinase Inhibitor Rilzabrutinib for Immune-Mediated DiseaseClaire L Langrish, J Michael Bradshaw, Michelle R Francesco, et al.
Journal of Intensive Care|March 7, 2017
Combined inhibition of C5 and CD14 efficiently attenuated the inflammatory response in a porcine model of meningococcal sepsisBernt C Hellerud, Hilde L Orrem, Knut Dybwik, et al.
Basic Research in Cardiology|March 5, 2017
Complement factor 5 blockade reduces porcine myocardial infarction size and improves immediate cardiac functionSoeren E Pischke, A Gustavsen, H L Orrem, et al.
Pageof 13

Showing results (111-120 of 130) with videos related to

Sort By:
Pageof 13
The Journal of Biological Chemistry|April 30, 2013
Bifunctional lipocalin ameliorates murine immune complex-induced acute lung injuryPietro Roversi, Bernhard Ryffel, Dieudonnée Togbe, et al.
British Journal of Pharmacology|October 17, 2022
Immunopathology of terminal complement activation and complement C5 blockade creating a pro-survival and organ-protective phenotype in traumaZhangsheng Yang, Miles A Nunn, Tuan D Le, et al.
Blood Advances|January 4, 2018
Use of the complement inhibitor Coversin to treat HSCT-associated TMATimothy H J Goodship, Fernando Pinto, Wynn H Weston-Davies, et al.
Brain : a Journal of Neurology|August 31, 2010
Systemic blockade of P2X3 and P2X2/3 receptors attenuates bone cancer pain behaviour in ratsTimothy K Y Kaan, Ping K Yip, Sital Patel, et al.
The Biochemical Journal|June 16, 2010
Crystal structure and functional characterization of an immunomodulatory salivary cystatin from the soft tick Ornithodoros moubataJirí Salát, Guido C Paesen, Pavlína Rezácová, et al.
Lancet (London, England)|November 5, 1997
HIV-1 viral load, phenotype, and resistance in a subset of drug-naive participants from the Delta trial. The National Virology Groups. Delta Virology Working Group and Coordinating CommitteeF Brun-Vézinet, C Boucher, C Loveday, et al.
Critical Care (London, England)|November 28, 2015
Combined inhibition of complement and CD14 improved outcome in porcine polymicrobial sepsisEspen W Skjeflo, Caroline Sagatun, Knut Dybwik, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 6, 2021
Preclinical Efficacy and Anti-Inflammatory Mechanisms of Action of the Bruton Tyrosine Kinase Inhibitor Rilzabrutinib for Immune-Mediated DiseaseClaire L Langrish, J Michael Bradshaw, Michelle R Francesco, et al.
Journal of Intensive Care|March 7, 2017
Combined inhibition of C5 and CD14 efficiently attenuated the inflammatory response in a porcine model of meningococcal sepsisBernt C Hellerud, Hilde L Orrem, Knut Dybwik, et al.
Basic Research in Cardiology|March 5, 2017
Complement factor 5 blockade reduces porcine myocardial infarction size and improves immediate cardiac functionSoeren E Pischke, A Gustavsen, H L Orrem, et al.
Pageof 13